EuroQol – Chair of the Board and Chair of the Executive Committee

We are pleased to announce that Prof. Nancy Devlin (University of Melbourne) and Prof. Feng Xie (McMaster University) were recently elected Chair of the Board of the EuroQol Research Foundation, and Chair of the Executive Committee of the EuroQol Group Association, respectively.

The EuroQol Research Foundation is a not-for-profit organization with a mission to provide tools for measuring and valuing health that aim to improve decisions about health and health care around the world. The 2024/2025 Annual Report of the Foundation, outlining its mission, vision and achievements can be found here. Professor Devlin has chaired the Board of the Foundation since 2021, and has been re-elected to serve a further 2-year term.

We are pleased to announce that Prof. Nancy Devlin (University of Melbourne) and Prof. Feng Xie (McMaster University) were recently elected Chair of the Board of the EuroQol Research Foundation, and Chair of the Executive Committee of the EuroQol Group Association, respectively.

The EuroQol Research Foundation is a not-for-profit organization with a mission to provide tools for measuring and valuing health that aim to improve decisions about health and health care around the world. The 2024/2025 Annual Report of the Foundation, outlining its mission, vision and achievements can be found here. Professor Devlin has chaired the Board of the Foundation since 2021, and has been re-elected to serve a further 2-year term.

Professor Devlin commented “I am delighted to be re-elected as chair of the Board of this important not-for-profit organisation. In the last year alone, the EuroQol Research Foundation provided its health related quality of life instruments to around 7,000 users – in 92% of cases, completely free of charge – and to channel over €6m to new research. The Foundation is helping to strengthen outcomes evidence worldwide, and it’s an honour to contribute to these efforts.”

The EuroQol Group Association comprises an international network of more than 120 multidisciplinary experts in health economics, patient-reported outcome measures, health-related quality of life, health technology assessment, and health policy. The Executive Committee is EuroQol’s principal scientific committee, responsible for leading the scientific strategy of the EuroQol Group, coordinating its research, development, and education and outreach activities, approving project funding; and maintaining strategic oversight of the overall research programme. Professor Xie has been elected as Chair of the Executive Committee for a 3-year term (2025-2028).

Professor Xie noted: “It is a great honour to chair the EuroQol’s Executive Committee. EuroQol has become a global leader and a primary funder of innovative research in health measurement and valuation. In the coming years we will launch new instruments tailored to diverse age groups and health conditions. One instrument in development, the EQ Health and Wellbeing (EQ-HWB), can be used across health, social care and carer settings. A key priority will also be to further engage and collaborate with stakeholders in HTA, HEOR, and health care systems to advance methods and applications of patient-reported outcome measures. I look forward to working with the Committee and the broader EuroQol membership as we undertake this vital work.”

We would like to express our sincere gratitude to all the members of the Board and Executive committees for their continued dedication, commit

ment, and invaluable contributions. The time, energy, and passion that they invest – often behind the scenes – make a real and lasting difference to the mission of EuroQol. The full list of members of the Board and Executive committees are as follows:

Board

• Nancy Devlin (Chair), Melbourne School of Population and Global Health, University of Melbourne
• Knut Stavem (Treasurer), Dept. of Health Services Research, Akershus University Hospital
• Wolfgang Greiner, Fakultat fur Gesundheitswissenschaften, University Bielefeld
• Andrew Lloyd, Director, Acaster Lloyd Consulting Ltd
• James Shaw, Patient-Centered Outcomes Lead, Takeda Pharmaceuticals

Executive Committee

• Feng Xie (Chair), Department of Clinical Epidemiology and Biostatistics and Centre for Health Economics and Policy Analysis, McMaster University
• Prof. Michal Jakubczyk (Deputy Chair), SGH Warsaw School of Economics
• Jan Busschbach, Medical Psychology and Psychotherapy, Erasmus MC
• Sarah Derrett, Department of Preventive and Social Medicine, University of Otago
• Nils Gutacker, Centre for Health Economics, University of York
• Michael Herdman, Director, Insight Consulting & Research
• Prof. Nan Luo, Saw Swee Hock School of Public Health, National University of Singapore
• Kim Rand-Hendriksen, Principal, Maths in Health
• Rosalie Viney, Centre for Health Economics Research and Evaluation, University of Technology Sydney

———

For more information on developments at EuroQol, see: Devlin NJ, Xie F, Slaap B, Stolk E. Measuring and Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond. Appl Health Econ Health Policy. 2025 Nov;23(6):947-960. doi: 10.1007/s40258-025-00989-2.